B
PFE icon

Brightworth’s Pfizer PFE Stock Holding History

Brightworth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.04M Sell
23,711
-55
-0.2% -$2.67K 0.11% 69
2022
Q2 		$1.25M Buy
23,766
+8,566
+56% +$437K 0.13% 65
2022
Q1 		$787K Sell
15,200
-15,643
-51% -$812K 0.08% 77
2021
Q4 		$1.82M Buy
30,843
+1,866
+6% +$92.5K 0.17% 57
2021
Q3 		$1.25M Buy
28,977
+2,570
+10% +$114K 0.11% 60
2021
Q2 		$1.03M Buy
26,407
+764
+3% +$29.7K 0.09% 58
2021
Q1 		$929K Buy
25,643
+17,536
+216% +$623K 0.09% 60
2020
Q4 		$298K Sell
8,107
-701
-8% -$25.7K 0.03% 84
2020
Q3 		$307K Hold
8,808
– – 0.03% 73
2020
Q2 		$273K Sell
8,808
-1,806
-17% -$61.4K 0.04% 71
2020
Q1 		$329K Sell
10,614
-527
-5% -$18K 0.06% 67
2019
Q4 		$414K Buy
11,141
+1,718
+18% +$61.2K 0.08% 71
2019
Q3 		$321K Buy
9,423
+264
+3% +$9.6K 0.07% 70
2019
Q2 		$376K Sell
9,159
-1,311
-13% -$52.1K 0.08% 66
2019
Q1 		$422K Sell
10,470
-989
-9% -$39.6K 0.09% 67
2018
Q4 		$475K Sell
11,459
-124
-1% -$5.15K 0.11% 61
2018
Q3 		$484K Buy
11,583
+2,795
+32% +$108K 0.11% 60
2018
Q2 		$302K Sell
8,788
-1,809
-17% -$61.8K 0.07% 72
2018
Q1 		$357K Sell
10,597
-747
-7% -$25.7K 0.08% 86
2017
Q4 		$390K Buy
11,344
+1,310
+13% +$44.7K 0.09% 79
2017
Q3 		$340K Buy
+10,034
New +$322K 0.08% 89

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brightworth's PFE Position: Q3 2022 in Review

Brightworth reduced its Pfizer (PFE) stake by 0.23% in Q3 2022, selling an estimated $2.67K and leaving 23,711 shares worth $1.04M. The position accounts for 0.11% of the portfolio, ranked #69.

Brightworth first reported a position in PFE in Q3 2017 and has held it in 21 quarters since. The position peaked at $1.82M in Q4 2021. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • Brightworth held 23,711 shares of Pfizer worth $1.04M as of Q3 2022.
  • Brightworth sold 55 Pfizer shares in Q3 2022, an estimated $2.67K.
  • Pfizer made up 0.11% of Brightworth's portfolio in Q3 2022, its #69 holding.
  • Brightworth first reported a position in Pfizer in Q3 2017 and has held it in 21 quarters since.
  • Brightworth's Pfizer position peaked at $1.82M in Q4 2021.
  • 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Brightworth's 13F filing for Q3 2022, filed 28 Oct 2022.